Search Results - "Kollia, G. D."

Refine Results
  1. 1

    Lack of a pharmacokinetic drug-drug interaction between lithium and valproate when co-administered with aripiprazole by Boulton, D. W., Kollia, G. D., Mallikaarjun, S., Kornhauser, D. M.

    “…Summary What is known and Objective:  The antipsychotic, aripiprazole, plus lithium or valproate demonstrates rapid and significant improvement in manic…”
    Get full text
    Journal Article
  2. 2

    Benefits and Disadvantages of Joint Hypermobility among Musicians by Larsson, Lars-Goran, Baum, John, Mudholkar, Govind S, Kollia, Georgia D

    Published in The New England journal of medicine (07-10-1993)
    “…Joint hypermobility, also known as joint laxity and defined as a range of motion in excess of normal, 1 is common enough to evoke curiosity, but until recently…”
    Get full text
    Journal Article
  3. 3

    A Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult Men by Gajjar, Diptee A., LaCreta, Frank P., Uderman, Howard D., Kollia, Georgia D., Duncan, Glenn, Birkhofer, Martin J., Grasela, Dennis M.

    Published in Pharmacotherapy (01-06-2000)
    “…Study Objectives. To examine single‐ and multiple‐dose safety, tolerability and pharmacokinetics of gatifloxacin administered as daily 1‐hour intravenous…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Open-Label, Nonrandomized Study of the Effects of Gatifloxacin on the Pharmacokinetics of Midazolam in Healthy Male Volunteers by Grasela, Dennis M., LaCreta, Frank P., Kollia, Georgia D., Randall, Diane M., Uderman, Howard D.

    Published in Pharmacotherapy (01-03-2000)
    “…Study Objective. To confirm findings from an in vitro study that showed gatifloxacin did not substantially inhibit cytochrome P450 (CYP) 3A4 model substrate…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Interchangeability of 400-mg Intravenous and Oral Gatifloxacin in Healthy Adults by LaCreta, Frank P., Kaul, Sanjeev, Kollia, Georgia D., Duncan, Glenn, Randall, Dianne M., Grasela, Dennis M.

    Published in Pharmacotherapy (01-06-2000)
    “…Study Objective. To evaluate the interchangeability of 400‐mg intravenous and oral doses of gatifloxacin. Design. Randomized, open‐label, crossover study…”
    Get full text
    Journal Article
  7. 7

    Age and Gender Effects on the Pharmacokinetics of Gatifloxacin by LaCreta, Frank P., Kollia, Georgia D., Duncan, Glenn, Behr, Douglas, Grasela, Dennis M.

    Published in Pharmacotherapy (01-06-2000)
    “…Study Objective. To compare the pharmacokinetics and safety of gatifloxacin in elderly (≥ 65 yrs) and young (18–45 yrs) men and women. Design. Open‐label,…”
    Get full text
    Journal Article
  8. 8

    Evaluation of the effect of food on the pharmacokinetics of avitriptan by Marathe, P. H., Greene, D. S., Kollia, G. D., Barbhaiya, R. H.

    Published in Biopharmaceutics & drug disposition (01-09-1998)
    “…Bioavailability of avitriptan was found to decrease significantly when administered 5 min after a standard high fat meal. The studies described herein were…”
    Get full text
    Journal Article
  9. 9

    Safety and Pharmacokinetics of a Single Oral Dose of Gatifloxacin in Patients with Moderate to Severe Hepatic Impairment by Grasela, Dennis M., Christofalo, Barbara, Kollia, Georgia D., Duncan, Glenn, Noveck, Robert, Manning Jr, James A., LaCreta, Frank P.

    Published in Pharmacotherapy (01-06-2000)
    “…Study Objectives. To assess the safety and pharmacokinetics of oral gatifloxacin 400 mg in subjects with and without hepatic impairment, and the need to modify…”
    Get full text
    Journal Article
  10. 10

    A pharmacokinetic interaction study of avitriptan and propranolol by Marathe, Punit H., Greene, Douglas S., Kollia, Georgia D., Barbhaiya, Rashmi H.

    Published in Clinical pharmacology and therapeutics (01-03-1998)
    “…Objective To assess whether a clinically significant change in the pharmacokinetics of avitriptan and propranolol is observed in healthy subjects after…”
    Get full text
    Journal Article
  11. 11

    The Effects of Age and Gender on the Single Dose Pharmacokinetics of Avitriptan Administered to Healthy Volunteers by Marathe, Punit H., Greene, Douglas S., Kollia, Georgia D., Barbhaiya, Rashmi H.

    Published in Journal of clinical pharmacology (01-10-1997)
    “…The effects of age and gender on the single dose pharmacokinetics of avitriptan and its three metabolites were assessed in 15 young men, 15 young women, 15…”
    Get full text
    Journal Article
  12. 12

    A Graphical Procedure for Comparing Goodness-of-Fit Tests by Mudholkar, Govind S., Kollia, Georgia D., Lin, C. Thomas, Patel, Kartik R.

    “…A method for comparing tests of normality using their `isotones', i.e. contours on the surfaces representing P-values, is proposed. Select a family of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Pharmacodynamics and Pharmacokinetics of Omapatrilat in Heart Failure by Kostis, John B., Klapholz, Marc, Delaney, Ms. Carol, Vesterqvist, Ole, Cohen, Marvin, Manning Jr, James A., Jemal, Mohammed, Kollia, Georgia D., Liao, Wei-Chi

    Published in Journal of clinical pharmacology (01-12-2001)
    “…The purpose of this study was to determine the pharmacodynamics and pharmacokinetics of omapatrilat, administered orally (25 mg) or intravenously (10 mg) in 19…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A Generalization of the Weibull Distribution with Application to the Analysis of Survival Data by Mudholkar, Govind S., Srivastava, Deo Kumar, Kollia, Georgia D.

    “…The Weibull distribution, which is frequently used for modeling survival data, is embedded in a larger family obtained by introducing an additional shape…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20